People

Gregory M. Bokar joined Transition Bio's board in 2026. He is Managing Director of UVB Capital Management, with experience in company formation, licensing, acquisitions and corporate governance. His earlier legal leadership roles included Flagship Pioneering, Sumitomo Pharma America Holdings, Sunovion and Elan.